Arl6ip5 Rat 1,2-dimethylhydrazine decreases expression ISO RGD:1331961 6480464 1,2-Dimethylhydrazine results in decreased expression of ARL6IP5 mRNA CTD PMID:22206623 Arl6ip5 Rat 1,2-dimethylhydrazine multiple interactions ISO RGD:1331961 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARL6IP5 mRNA CTD PMID:22206623 Arl6ip5 Rat 17beta-estradiol affects expression ISO RGD:1344465 6480464 Estradiol affects the expression of ARL6IP5 mRNA CTD PMID:14699072 Arl6ip5 Rat 17beta-estradiol decreases expression ISO RGD:1344465 6480464 Estradiol results in decreased expression of ARL6IP5 mRNA CTD PMID:23019147 Arl6ip5 Rat 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1331961 6480464 2,2',4,4'-tetrabromodiphenyl ether affects the expression of ARL6IP5 mRNA CTD PMID:30294300 Arl6ip5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1331961 6480464 Tetrachlorodibenzodioxin affects the expression of ARL6IP5 mRNA CTD PMID:21570461 Arl6ip5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARL6IP5 mRNA CTD PMID:33387578 Arl6ip5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ARL6IP5 mRNA CTD PMID:34747641 Arl6ip5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1331961 6480464 Tetrachlorodibenzodioxin results in increased expression of ARL6IP5 mRNA CTD PMID:15034205|PMID:15667827|PMID:18691609|PMID:19770486|PMID:19933214|PMID:25270620|PMID:26290441|PMID:32553695 Arl6ip5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1331961 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression more ... CTD PMID:25975270 Arl6ip5 Rat 2-hydroxypropanoic acid increases expression ISO RGD:1344465 6480464 Lactic Acid results in increased expression of ARL6IP5 mRNA CTD PMID:30851411 Arl6ip5 Rat 2-methylcholine affects expression ISO RGD:1344465 6480464 beta-methylcholine affects the expression of ARL6IP5 mRNA CTD PMID:21179406 Arl6ip5 Rat 3-methylcholanthrene increases expression ISO RGD:1331961 6480464 Methylcholanthrene results in increased expression of ARL6IP5 mRNA CTD PMID:20713471 Arl6ip5 Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:1344465 6480464 bisphenol S results in increased expression of ARL6IP5 protein CTD PMID:34186270 Arl6ip5 Rat 4-hydroxyphenyl retinamide affects expression ISO RGD:1344465 6480464 Fenretinide affects the expression of ARL6IP5 CTD PMID:16720286 Arl6ip5 Rat 5-aza-2'-deoxycytidine affects expression ISO RGD:1344465 6480464 Decitabine affects the expression of ARL6IP5 mRNA CTD PMID:23300844 Arl6ip5 Rat 5-fluorouracil multiple interactions ISO RGD:1344465 6480464 ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin]; ARL6IP5 protein more ... CTD PMID:22452940 Arl6ip5 Rat 5-formyltetrahydrofolic acid multiple interactions ISO RGD:1344465 6480464 ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin]; ARL6IP5 protein more ... CTD PMID:22452940 Arl6ip5 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ARL6IP5 mRNA CTD PMID:24780913 Arl6ip5 Rat 7,12-dimethyltetraphene multiple interactions ISO RGD:1331961 6480464 [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 more ... CTD PMID:32553695 Arl6ip5 Rat 7,12-dimethyltetraphene increases expression ISO RGD:1331961 6480464 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARL6IP5 mRNA CTD PMID:32553695 Arl6ip5 Rat acetylsalicylic acid increases expression ISO RGD:1344465 6480464 Aspirin results in increased expression of ARL6IP5 mRNA CTD PMID:15928584 Arl6ip5 Rat all-trans-retinoic acid increases expression ISO RGD:1344465 6480464 Tretinoin results in increased expression of ARL6IP5 mRNA; Tretinoin results in increased expression of ARL6IP5 more ... CTD PMID:16430862|PMID:16468075|PMID:16922813|PMID:33167477 Arl6ip5 Rat all-trans-retinoic acid affects expression ISO RGD:1344465 6480464 Tretinoin affects the expression of ARL6IP5 CTD PMID:16720286 Arl6ip5 Rat all-trans-retinoic acid increases response to substance ISO RGD:1344465 6480464 ARL6IP5 protein results in increased susceptibility to Tretinoin CTD PMID:16922813 Arl6ip5 Rat all-trans-retinoic acid multiple interactions ISO RGD:1344465 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of ARL6IP5 mRNA; ARL6IP5 protein affects more ... CTD PMID:16468075|PMID:16922813 Arl6ip5 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ARL6IP5 mRNA CTD PMID:16483693 Arl6ip5 Rat Aroclor 1254 increases expression ISO RGD:1331961 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of ARL6IP5 mRNA CTD PMID:25270620 Arl6ip5 Rat arsenite(3-) increases expression ISO RGD:1331961 6480464 arsenite results in increased expression of ARL6IP5 mRNA CTD PMID:15894712 Arl6ip5 Rat arsenite(3-) multiple interactions ISO RGD:1331961 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of ARL6IP5 mRNA CTD PMID:15894712 Arl6ip5 Rat arsenous acid increases expression ISO RGD:1344465 6480464 Arsenic Trioxide results in increased expression of ARL6IP5 protein CTD PMID:16430862 Arl6ip5 Rat arsenous acid increases response to substance ISO RGD:1344465 6480464 ARL6IP5 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:18387645 Arl6ip5 Rat arsenous acid multiple interactions ISO RGD:1344465 6480464 [Arsenic Trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of more ... CTD PMID:16468075|PMID:18387645 Arl6ip5 Rat benzene-1,2,4-triol decreases expression ISO RGD:1344465 6480464 hydroxyhydroquinone results in decreased expression of ARL6IP5 mRNA CTD PMID:17572062 Arl6ip5 Rat benzo[a]pyrene multiple interactions ISO RGD:1331961 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of ARL6IP5 mRNA; [Benzo(a)pyrene results in increased more ... CTD PMID:15894712|PMID:32553695 Arl6ip5 Rat benzo[a]pyrene increases expression ISO RGD:1331961 6480464 Benzo(a)pyrene metabolite results in increased expression of ARL6IP5 mRNA; Benzo(a)pyrene results in increased expression of more ... CTD PMID:15034205|PMID:15894712|PMID:19770486|PMID:20713471|PMID:21715664|PMID:32553695 Arl6ip5 Rat beta-lapachone decreases expression ISO RGD:1344465 6480464 beta-lapachone results in decreased expression of ARL6IP5 mRNA CTD PMID:38218311 Arl6ip5 Rat bexarotene increases expression ISO RGD:1344465 6480464 bexarotene results in increased expression of ARL6IP5 mRNA CTD PMID:17178900 Arl6ip5 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ARL6IP5 mRNA CTD PMID:25181051 Arl6ip5 Rat bisphenol A decreases expression ISO RGD:1344465 6480464 bisphenol A results in decreased expression of ARL6IP5 protein CTD PMID:37664457 Arl6ip5 Rat bisphenol A increases expression ISO RGD:1344465 6480464 bisphenol A results in increased expression of ARL6IP5 protein CTD PMID:33376534|PMID:34186270|PMID:37567409 Arl6ip5 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ARL6IP5 mRNA CTD PMID:30816183|PMID:32528016 Arl6ip5 Rat bisphenol AF increases expression ISO RGD:1344465 6480464 bisphenol AF results in increased expression of ARL6IP5 protein CTD PMID:34186270 Arl6ip5 Rat Bisphenol B increases expression ISO RGD:1344465 6480464 bisphenol B results in increased expression of ARL6IP5 protein CTD PMID:34186270 Arl6ip5 Rat bisphenol F increases expression ISO RGD:1344465 6480464 bisphenol F results in increased expression of ARL6IP5 protein CTD PMID:34186270 Arl6ip5 Rat Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of ARL6IP5 protein CTD PMID:28903499 Arl6ip5 Rat carbon nanotube increases expression ISO RGD:1331961 6480464 Nanotubes, Carbon analog results in increased expression of ARL6IP5 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681|PMID:25620056 Arl6ip5 Rat chloropicrin increases expression ISO RGD:1344465 6480464 chloropicrin results in increased expression of ARL6IP5 mRNA CTD PMID:26352163 Arl6ip5 Rat chromium(6+) multiple interactions ISO RGD:1344465 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression more ... CTD PMID:38479592 Arl6ip5 Rat cisplatin affects expression ISO RGD:1344465 6480464 Cisplatin affects the expression of ARL6IP5 mRNA CTD PMID:23300844 Arl6ip5 Rat cisplatin multiple interactions ISO RGD:1344465 6480464 ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin] CTD PMID:22452940 Arl6ip5 Rat clofibrate decreases expression ISO RGD:1331961 6480464 Clofibrate results in decreased expression of ARL6IP5 mRNA CTD PMID:17585979 Arl6ip5 Rat copper atom decreases expression EXP 6480464 Copper results in decreased expression of ARL6IP5 mRNA CTD PMID:30556269 Arl6ip5 Rat copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ARL6IP5 mRNA CTD PMID:30556269 Arl6ip5 Rat copper(II) sulfate decreases expression ISO RGD:1344465 6480464 Copper Sulfate results in decreased expression of ARL6IP5 mRNA CTD PMID:19549813 Arl6ip5 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ARL6IP5 mRNA CTD PMID:26577399 Arl6ip5 Rat cyclosporin A decreases expression ISO RGD:1344465 6480464 Cyclosporine results in decreased expression of ARL6IP5 mRNA CTD PMID:20106945|PMID:25562108 Arl6ip5 Rat cytarabine increases expression ISO RGD:1344465 6480464 Cytarabine results in increased expression of ARL6IP5 protein CTD PMID:16430862 Arl6ip5 Rat diarsenic trioxide increases response to substance ISO RGD:1344465 6480464 ARL6IP5 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:18387645 Arl6ip5 Rat diarsenic trioxide increases expression ISO RGD:1344465 6480464 Arsenic Trioxide results in increased expression of ARL6IP5 protein CTD PMID:16430862 Arl6ip5 Rat diarsenic trioxide multiple interactions ISO RGD:1344465 6480464 [Arsenic Trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of more ... CTD PMID:16468075|PMID:18387645 Arl6ip5 Rat Dibutyl phosphate affects expression ISO RGD:1344465 6480464 di-n-butylphosphoric acid affects the expression of ARL6IP5 mRNA CTD PMID:37042841 Arl6ip5 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ARL6IP5 mRNA CTD PMID:21266533 Arl6ip5 Rat dicrotophos decreases expression ISO RGD:1344465 6480464 dicrotophos results in decreased expression of ARL6IP5 mRNA CTD PMID:28302478 Arl6ip5 Rat diuron decreases expression ISO RGD:1344465 6480464 Diuron results in decreased expression of ARL6IP5 mRNA CTD PMID:35967413 Arl6ip5 Rat doxorubicin increases expression ISO RGD:1344465 6480464 Doxorubicin results in increased expression of ARL6IP5 protein CTD PMID:16430862 Arl6ip5 Rat etoposide increases response to substance ISO RGD:1344465 6480464 ARL6IP5 protein results in increased susceptibility to Etoposide CTD PMID:19492242 Arl6ip5 Rat etoposide decreases expression ISO RGD:1344465 6480464 Etoposide results in decreased expression of ARL6IP5 CTD PMID:19492242 Arl6ip5 Rat fipronil increases expression EXP 6480464 fipronil results in increased expression of ARL6IP5 mRNA CTD PMID:31881178 Arl6ip5 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of ARL6IP5 mRNA CTD PMID:24136188 Arl6ip5 Rat folic acid multiple interactions ISO RGD:1331961 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARL6IP5 mRNA CTD PMID:22206623 Arl6ip5 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ARL6IP5 mRNA CTD PMID:22061828|PMID:33387578 Arl6ip5 Rat hemin increases expression ISO RGD:1344465 6480464 Hemin results in increased expression of ARL6IP5 protein CTD PMID:16430862 Arl6ip5 Rat hydralazine multiple interactions ISO RGD:1344465 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL6IP5 mRNA CTD PMID:17183730 Arl6ip5 Rat hydrogen peroxide multiple interactions ISO RGD:1344465 6480464 [arsenic trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of more ... CTD PMID:18387645 Arl6ip5 Rat ivermectin decreases expression ISO RGD:1344465 6480464 Ivermectin results in decreased expression of ARL6IP5 protein CTD PMID:32959892 Arl6ip5 Rat kojic acid increases expression ISO RGD:1344465 6480464 kojic acid results in increased expression of ARL6IP5 mRNA CTD PMID:16595896 Arl6ip5 Rat Mesaconitine decreases expression EXP 6480464 mesaconitine results in decreased expression of ARL6IP5 protein CTD PMID:37182599 Arl6ip5 Rat methylmercury chloride decreases expression ISO RGD:1344465 6480464 methylmercuric chloride results in decreased expression of ARL6IP5 mRNA CTD PMID:23179753 Arl6ip5 Rat morphine multiple interactions ISO RGD:1344465 6480464 ARL6IP5 mutant form inhibits the reaction [Morphine results in increased expression of OPRD1 protein]; ARL6IP5 more ... CTD PMID:21600884 Arl6ip5 Rat morphine increases expression EXP 6480464 Morphine results in increased expression of ARL6IP5 protein CTD PMID:21600884 Arl6ip5 Rat morphine multiple interactions EXP 6480464 ARL6IP5 mutant form inhibits the reaction [Morphine results in increased expression of OPRD1 protein]; ARL6IP5 more ... CTD PMID:21600884 Arl6ip5 Rat N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [ARL6IP5 mutant form inhibits the reaction [Morphine results in increased more ... CTD PMID:21600884 Arl6ip5 Rat nickel subsulfide increases expression EXP 6480464 nickel subsulfide results in increased expression of ARL6IP5 mRNA CTD PMID:21086188 Arl6ip5 Rat oxaliplatin multiple interactions ISO RGD:1344465 6480464 ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] CTD PMID:22452940 Arl6ip5 Rat ozone multiple interactions ISO RGD:1344465 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ARL6IP5 mRNA CTD PMID:35430440 Arl6ip5 Rat paracetamol affects expression ISO RGD:1331961 6480464 Acetaminophen affects the expression of ARL6IP5 mRNA CTD PMID:17562736 Arl6ip5 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ARL6IP5 mRNA CTD PMID:33387578 Arl6ip5 Rat paracetamol decreases expression ISO RGD:1344465 6480464 Acetaminophen results in decreased expression of ARL6IP5 mRNA CTD PMID:21420995|PMID:29067470 Arl6ip5 Rat paraquat affects response to substance ISO RGD:1331961 6480464 ARL6IP5 protein affects the susceptibility to Paraquat CTD PMID:28428137 Arl6ip5 Rat paraquat increases expression ISO RGD:1331961 6480464 Paraquat results in increased expression of ARL6IP5 CTD PMID:28428137 Arl6ip5 Rat paraquat multiple interactions ISO RGD:1331961 6480464 ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein]; ARL6IP5 protein affects more ... CTD PMID:28428137 Arl6ip5 Rat paraquat increases expression ISO RGD:1344465 6480464 Paraquat results in increased expression of ARL6IP5 protein CTD PMID:28428137 Arl6ip5 Rat paraquat multiple interactions ISO RGD:1344465 6480464 ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein]; ARL6IP5 protein affects more ... CTD PMID:28428137 Arl6ip5 Rat parathion decreases expression ISO RGD:1331961 6480464 Parathion results in decreased expression of ARL6IP5 mRNA CTD PMID:34813904 Arl6ip5 Rat perfluorooctanoic acid decreases expression ISO RGD:1344465 6480464 perfluorooctanoic acid results in decreased expression of ARL6IP5 protein CTD PMID:26879310 Arl6ip5 Rat phenobarbital increases expression ISO RGD:1331961 6480464 Phenobarbital results in increased expression of ARL6IP5 mRNA CTD PMID:19270015 Arl6ip5 Rat phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1344465 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Tretinoin results in increased expression of ARL6IP5 mRNA] CTD PMID:16468075 Arl6ip5 Rat phorbol 13-acetate 12-myristate increases expression ISO RGD:1344465 6480464 Tetradecanoylphorbol Acetate results in increased expression of ARL6IP5 protein CTD PMID:16430862 Arl6ip5 Rat phoxim affects expression ISO RGD:1344465 6480464 phoxim affects the expression of ARL6IP5 protein CTD PMID:15799245 Arl6ip5 Rat piroxicam increases expression ISO RGD:1344465 6480464 Piroxicam results in increased expression of ARL6IP5 mRNA CTD PMID:21858171 Arl6ip5 Rat potassium chromate decreases expression ISO RGD:1344465 6480464 potassium chromate(VI) results in decreased expression of ARL6IP5 mRNA CTD PMID:22714537 Arl6ip5 Rat quercetin decreases expression ISO RGD:1344465 6480464 Quercetin results in decreased expression of ARL6IP5 mRNA CTD PMID:21632981 Arl6ip5 Rat rac-lactic acid increases expression ISO RGD:1344465 6480464 Lactic Acid results in increased expression of ARL6IP5 mRNA CTD PMID:30851411 Arl6ip5 Rat rotenone decreases expression ISO RGD:1331961 6480464 Rotenone results in decreased expression of ARL6IP5 mRNA CTD PMID:23186747 Arl6ip5 Rat SB 431542 multiple interactions ISO RGD:1344465 6480464 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ARL6IP5 more ... CTD PMID:37664457 Arl6ip5 Rat temozolomide decreases expression ISO RGD:1344465 6480464 Temozolomide results in decreased expression of ARL6IP5 mRNA CTD PMID:31758290 Arl6ip5 Rat tert-butyl hydroperoxide decreases expression ISO RGD:1344465 6480464 tert-Butylhydroperoxide results in decreased expression of ARL6IP5 mRNA CTD PMID:15336504 Arl6ip5 Rat tetrachloromethane increases expression ISO RGD:1331961 6480464 Carbon Tetrachloride results in increased expression of ARL6IP5 mRNA CTD PMID:27339419|PMID:31919559 Arl6ip5 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ARL6IP5 mRNA CTD PMID:34492290 Arl6ip5 Rat thiram decreases expression ISO RGD:1344465 6480464 Thiram results in decreased expression of ARL6IP5 mRNA CTD PMID:38568856 Arl6ip5 Rat triphenyl phosphate affects expression ISO RGD:1344465 6480464 triphenyl phosphate affects the expression of ARL6IP5 mRNA CTD PMID:37042841 Arl6ip5 Rat trovafloxacin increases expression ISO RGD:1331961 6480464 trovafloxacin results in increased expression of ARL6IP5 mRNA CTD PMID:35537566 Arl6ip5 Rat valproic acid multiple interactions ISO RGD:1344465 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL6IP5 mRNA CTD PMID:17183730 Arl6ip5 Rat valproic acid increases expression ISO RGD:1344465 6480464 Valproic Acid results in increased expression of ARL6IP5 mRNA CTD PMID:19101580|PMID:23179753|PMID:27188386 Arl6ip5 Rat valproic acid affects expression ISO RGD:1344465 6480464 Valproic Acid affects the expression of ARL6IP5 mRNA CTD PMID:25979313 Arl6ip5 Rat zinc atom decreases expression ISO RGD:1344465 6480464 Zinc deficiency results in decreased expression of ARL6IP5 mRNA CTD PMID:22171008 Arl6ip5 Rat zinc(0) decreases expression ISO RGD:1344465 6480464 Zinc deficiency results in decreased expression of ARL6IP5 mRNA CTD PMID:22171008